Company Presentation • 26 Feb 2025 22:00
Company Presentation • 15 Nov 2024 01:00
Company Presentation • 28 Aug 2024 22:30
Company Presentation • 03 Jun 2024 00:00
Company Presentation • 28 Feb 2024 22:00
ENTITY
SMARTSCORE: 3/5
Mesoblast Ltd (MSB AU)
Mesoblast Ltd (MSB AU)
58
Analysis
Health Care • Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
morex